Skip to main content
Premium Trial:

Request an Annual Quote

Meanwhile, the Pricing Folks at Nature and Science Rejoice

Peter Suber, who spends his days thinking about open access issues, posted this entry on his blog -- it's an excerpt from a press release issued by Yale explaining its libraries' decision to stop supporting BioMed Central's Open Access publishing effort. The problem was financial: the libraries paid for the author page charges, which allowed those papers to be freely available online. The first year's charges came in under $5,000 but soared to more than $31,000 in 2006, the second year. This year looks to continue that trend, the libraries said, adding that the business model was "unsustainable" and "failed to provide a viable long-term revenue base built upon logical and scalable options," according to the press release.

Looks like it's back to the drawing board for at least some open-access proponents.


The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.